These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34630437)

  • 1. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
    Roudko V; Cimen Bozkus C; Greenbaum B; Lucas A; Samstein R; Bhardwaj N
    Front Immunol; 2021; 12():757804. PubMed ID: 34630437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome.
    Elze L; van der Post RS; Vos JR; Mensenkamp AR; de Hullu MSC; Nagtegaal ID; Hoogerbrugge N; de Voer RM; Ligtenberg MJL
    J Natl Cancer Inst; 2023 Jul; 115(7):853-860. PubMed ID: 37018159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omic analysis in normal colon organoids highlights MSH4 as a novel marker of defective mismatch repair in Lynch syndrome and microsatellite instability.
    Devall M; Ali MW; Eaton S; Weisenberger DJ; Reilley MJ; Powell SM; Li L; Casey G
    Cancer Med; 2023 Jun; 12(12):13551-13572. PubMed ID: 37162286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
    Bellone S; Roque DM; Siegel ER; Buza N; Hui P; Bonazzoli E; Guglielmi A; Zammataro L; Nagarkatti N; Zaidi S; Lee J; Silasi DA; Huang GS; Andikyan V; Damast S; Clark M; Azodi M; Schwartz PE; Tymon-Rosario JR; Harold JA; Mauricio D; Zeybek B; Menderes G; Altwerger G; Ratner E; Alexandrov LB; Iwasaki A; Kong Y; Song E; Dong W; Elvin JA; Choi J; Santin AD
    Cancer; 2022 Mar; 128(6):1206-1218. PubMed ID: 34875107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
    Gebert J; Gelincik O; Oezcan-Wahlbrink M; Marshall JD; Hernandez-Sanchez A; Urban K; Long M; Cortes E; Tosti E; Katzenmaier EM; Song Y; Elsaadi A; Deng N; Vilar E; Fuchs V; Nelius N; Yuan YP; Ahadova A; Sei S; Shoemaker RH; Umar A; Wei L; Liu S; Bork P; Edelmann W; von Knebel Doeberitz M; Lipkin SM; Kloor M
    Gastroenterology; 2021 Oct; 161(4):1288-1302.e13. PubMed ID: 34224739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Liu YL; Weigelt B
    Cancer; 2024 May; 130(10):1733-1746. PubMed ID: 38422006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune Biology of Microsatellite-Unstable Cancer.
    Kloor M; von Knebel Doeberitz M
    Trends Cancer; 2016 Mar; 2(3):121-133. PubMed ID: 28741532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
    André T; Cohen R; Salem ME
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.
    Ghidini M; Lampis A; Mirchev MB; Okuducu AF; Ratti M; Valeri N; Hahne JC
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for immunoprevention of DNA mismatch repair deficient cancers.
    Hernandez-Sanchez A; Grossman M; Yeung K; Sei SS; Lipkin S; Kloor M
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a vaccine to prevent cancer in Lynch syndrome patients.
    von Knebel Doeberitz M; Kloor M
    Fam Cancer; 2013 Jun; 12(2):307-12. PubMed ID: 23760517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of microsatellite instability in colorectal cancer.
    Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
    Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.
    Reuschenbach M; Kloor M; Morak M; Wentzensen N; Germann A; Garbe Y; Tariverdian M; Findeisen P; Neumaier M; Holinski-Feder E; von Knebel Doeberitz M
    Fam Cancer; 2010 Jun; 9(2):173-9. PubMed ID: 19957108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
    Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
    Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review.
    Li N; Wan Z; Lu D; Chen R; Ye X
    Front Immunol; 2022; 13():1088683. PubMed ID: 36703977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
    Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
    Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent discoveries in the molecular genetics of Lynch syndrome.
    Boland CR
    Fam Cancer; 2016 Jul; 15(3):395-403. PubMed ID: 27038793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer.
    Yamamoto H; Adachi Y; Taniguchi H; Kunimoto H; Nosho K; Suzuki H; Shinomura Y
    World J Gastroenterol; 2012 Jun; 18(22):2745-55. PubMed ID: 22719182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.